Healthcare -
Biotechnology - NASDAQ - US
$ 59.76
1.03 %
$ 7.36 B
Market Cap
17.42
P/E
HALO - PRE-TAX INCOME
Pre-tax Income HALO - Halozyme Therapeutics, Inc.
557 M
LAST VALUE
49.61%
2 YEAR CAGR
57.56%
5 YEAR CAGR
26.08%
10 YEAR CAGR